Synecor

Synecor, LLC is a privately held medical device business accelerator and incubator founded in 2000 by William Starling and Dr. Richard Stack, headquartered in Chapel Hill, North Carolina, with historical operations also in Menlo Park, California. The firm is focused on creating highly proprietary, disruptive technologies in the largest medical device and combination drug/device markets, specializing primarily in cardiovascular, metabolic, and surgical innovation. The firm operates a proprietary New Technology Engine model that provides end-to-end support for launching medical device companies, from concept development and intellectual property creation through clinical evaluation and commercialization. Portfolio companies founded by Synecor include BaroSense, InnerPulse, TransEnterix, and BioStent, collectively having raised more than $123 million. The firm raised approximately $32 million to support its incubation platform and maintains partnerships with major academic medical centers, venture capital firms, and device corporations.